Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bakris

Showing results (381-390 of 991) with videos related to

Pageof 100
Sort By:
Current Hypertension Reports|January 30, 2014
The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertensionJames Brian Byrd, George Bakris, Kenneth Jamerson
Nature Reviews. Nephrology|November 17, 2010
Epidemiology of hypertensive kidney diseaseSuneel Udani, Ivana Lazich, George L Bakris
British Journal of Pharmacology|November 23, 2021
Novel non-steroidal mineralocorticoid receptor antagonists in cardiorenal diseaseUlrich Kintscher, George L Bakris, Peter Kolkhof
Nature Reviews. Nephrology|January 30, 2010
Pediatrics: blood pressure target for renoprotection in childrenRobert H Mak, Joseph Flynn, George Bakris
The New England Journal of Medicine|March 17, 2021
Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes. ReplyGeorge L Bakris, Rajiv Agarwal, Gerasimos Filippatos, et al.
Current Diabetes Reports|April 20, 2022
Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor AgonistsScott Cohen, Hillel Sternlicht, George L Bakris
Cardiology Clinics|October 13, 2010
Pathogenesis and clinical physiology of hypertensionMukesh Singh, George A Mensah, George Bakris
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 7, 2019
Barriers to guideline mandated renin-angiotensin inhibitor use: focus on hyperkalaemiaShilpa Vijayakumar, Javed Butler, George L Bakris
Current Diabetes Reports|May 11, 2004
Management of hypertension in the cardiometabolic syndrome and diabetesNitin Khosla, Peter Hart, George L Bakris
Diabetes Care|March 22, 2018
Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 DiabetesIan H de Boer, George L Bakris
Pageof 100

Showing results (381-390 of 991) with videos related to

Sort By:
Pageof 100
Current Hypertension Reports|January 30, 2014
The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertensionJames Brian Byrd, George Bakris, Kenneth Jamerson
Nature Reviews. Nephrology|November 17, 2010
Epidemiology of hypertensive kidney diseaseSuneel Udani, Ivana Lazich, George L Bakris
British Journal of Pharmacology|November 23, 2021
Novel non-steroidal mineralocorticoid receptor antagonists in cardiorenal diseaseUlrich Kintscher, George L Bakris, Peter Kolkhof
Nature Reviews. Nephrology|January 30, 2010
Pediatrics: blood pressure target for renoprotection in childrenRobert H Mak, Joseph Flynn, George Bakris
The New England Journal of Medicine|March 17, 2021
Finerenone and Chronic Kidney Disease Outcomes in Type 2 Diabetes. ReplyGeorge L Bakris, Rajiv Agarwal, Gerasimos Filippatos, et al.
Current Diabetes Reports|April 20, 2022
Mineralocorticoid Receptor Antagonists in the Treatment of Diabetic Kidney Disease: Their Application in the Era of SGLT2 Inhibitors and GLP-1 Receptor AgonistsScott Cohen, Hillel Sternlicht, George L Bakris
Cardiology Clinics|October 13, 2010
Pathogenesis and clinical physiology of hypertensionMukesh Singh, George A Mensah, George Bakris
European Heart Journal Supplements : Journal of the European Society of Cardiology|March 7, 2019
Barriers to guideline mandated renin-angiotensin inhibitor use: focus on hyperkalaemiaShilpa Vijayakumar, Javed Butler, George L Bakris
Current Diabetes Reports|May 11, 2004
Management of hypertension in the cardiometabolic syndrome and diabetesNitin Khosla, Peter Hart, George L Bakris
Diabetes Care|March 22, 2018
Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 DiabetesIan H de Boer, George L Bakris
Pageof 100